Skip to main content
2025 WFH Comprehensive Care Summit Main banner

Alok Srivastava, MD, FRACP, FRCPA, FRCP

Head, Haematology Research Unit
St. John's Research Institute, Bengaluru, India
Bengaluru, India

Alok Srivastava, MD, FRACP, FRCPA, FRCP
St. John’s Research Institute & St. John’s Medical College Hospital, Bengaluru, India

Alok Srivastava is Professor-Research and Head, Haematology Research Unit, St. John’s Research Institute and Senior Consultant, Department of Clinical Haematology in the St. John’s Medical College Hospital at Bengaluru, India. Prof. Srivastava has been involved with the management of patients with bleeding disorders for over 30 years. His recent focus has been on novel therapies including gene therapy for hemophilia.

Prof. Srivastava is President of the Indian Association for Haemophilia & Allied Disorders. He is also the Chairman of the Association for Haemophilia & Allied Disorders – Asia-Pacific. He was the chair of the FVIII/IX subcommittee of the SSC of the ISTH from 2006-2010 and currently serves on the SSC Gene Therapy steering committee. He is a member of the board of the WFH and was the WFH Vice-President (Medical) from 2012-2014. He has led the writing group for all three editions of the WFH guidelines for the management of hemophilia.

Disclosure information not submitted.

Presentation(s):